KRYS Kathryn Romano sells $131K worth of shares
Mar 27, 2025, 10:34 AM
0.00%
What does KRYS do
Krystal Biotech, based in Pittsburgh, focuses on developing genetic medicines for diseases with high unmet needs, employing 229 staff since its IPO in September 2017. Its products include VYJUVEK for DEB and others targeting cystic fibrosis and solid tumors.
Kathryn Romano sold 750 shares of KRYS on 27 February at $175.22 per share, worth a total of $131K. They now own 12,604 KRYS shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.